Natalie Rath

Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)

Silvio Danese, Séverine Vermeire, Paul Hellstern et al. · Gut · 2017 · 174 citations · Full text

Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study

Silvio Danese, Maria Kłopocka, Ellen Scherl et al. · Clinical Gastroenterology and Hepatology · 2021 · 81 citations · Full text

Inflammation, Single-arm Study, Autoimmune Disease +10

Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD)

Robert M. Ward, Brinda Tammara, Sandra Sullivan et al. · European Journal of Clinical Pharmacology · 2010 · 65 citations

Neonatology, Gastroenterology, Pediatrics +7

Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

David Fiorentino, Aaron R. Mangold, Victoria P. Werth et al. · The Lancet · 2025 · 36 citations

Rheumatology, Translational Medicine, Autoimmune Disease +7

A Multicenter, Randomized, Open-Label, Pharmacokinetics and Safety Study of Pantoprazole Tablets in Children and Adolescents Aged 6 Through 16 Years With Gastroesophageal Reflux Disease

Robert M. Ward, Gregory L. Kearns, Brinda Tammara et al. · The Journal of Clinical Pharmacology · 2010 · 32 citations · Full text

Drug Safety, Pantoprazole Tablets, Gastric Acid Suppression +11